跳至主要内容
临床试验/NCT02611869
NCT02611869Unknown不适用

Effect of Cryoballoon Versus Radiofrequency Ablation for Pulmonary Vein Isolation on Left Atrial Function in Patients With Non-valvular Paroxysmal Atrial Fibrillation

G.Gennimatas General Hospital3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2015年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
3
主要终点
Change in left atrial ejection fraction

研究概览

简要总结

120 consecutive patients with paroxysmal AF, slated for PV isolation, will be randomly assigned to RF or cryoballoon ablation (in a 1:2 allocation scheme). Real-time 3D echocardiography (RT3DE) will be performed before the ablation procedure and 1 month post-ablation. The RT3DE datasets will be stored digitally and quantitative analyses will be performed off-line at a core echo laboratory. Quantification of left atrial volumes will be performed and left atrial functional quantification will be performed by calculating the following indices: Left atrial ejection fraction, Active atrial emptying fraction, Passive atrial emptying fraction, Atrial expansion index. All patients will be hospitalized for 48 hours post-ablation. Blood samples will be obtained at 12-hour intervals to measure troponin T with a high-sensitivity assay, as well as other biochemical parameters.

详细描述

The study will involve 2 study interventions, cryoballoon and RF ablation, to which patients will be randomly assigned (in a 2:1 allocation scheme). Randomization will be performed centrally using a random number generator - the following short script will be used in R language to generate a random sequence with a 2:1 probability of assignment to cryoballoon versus RF.

Each patient's randomization will be known only to the operator of the ablation procedure (and of course to the investigator who will attend the procedure to record procedural parameters, complications, outcome etc.). All personnel involved in patient follow-up and echo data analysis will be blinded to patient randomization (patient records will be accompanied by a randomization number corresponding to a masked randomization list kept in digital form at the coordinating center, which will be unlocked after completion of the last patient's follow-up). The Ablation Procedure Data Sheet will be filed separately from other CRF documents to maintain blinding.

  1. RF ablation Antral PV isolation will be performed in all patients randomized to RF ablation, without additional ablation of extrapulmonary sites, with the exception of individuals with documented typical atrial flutter.

An irrigated radiofrequency ablation catheter will be used to perform ablation, with the aid of electroanatomical mapping (Carto 3, Biosense Webster), following a single transeptal puncture. Pulmonary vein potentials will be recorded with a circular mapping catheter (Lasso® NAV eco, Biosense Webster) before, during and following antral ablation (the default strategy will be to create two ablation lines, around the two ipsilateral pulmonary veins, unless left atrial anatomy dictates another approach). The endpoint of the ablation procedure will be entrance and exit block in all pulmonary veins. A waiting time of 20-30 minutes will be observed after initial pulmonary vein isolation and further ablation will be performed in case of reconduction between the veins and the atrium.

Patients with a history of documented sustained typical atrial flutter before the ablation procedure will additionally undergo cavotricuspid isthmus ablation. Use of additional modalities, including intracardiac ultrasound and integration of computed tomography or magnetic resonance imaging anatomical data of the left atrium, will be left to the discretion of the operators.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least two AF episodes within the last 12 months (either self-terminating within 7 days or cardioverted, medically or electrically, in less than 48 hours),
  • AF episodes should have been symptomatic on at least 2 occasions within the last 12 months,
  • Failure of at least one class I or III antiarrhythmic to prevent AF paroxysms,
  • Age 40-80 years old.

排除标准

  • Previous left atrial ablation procedure,
  • Left atrial diameter >50 mm on TTE (parasternal long axis view),
  • Known primary electrical heart disease (e.g. Brugada syndrome),
  • Presence of atrial thrombus,
  • Prosthetic valve at any position,
  • Moderate/severe mitral stenosis,
  • Severe mitral regurgitation,
  • Active infectious disease or malignancy,
  • Moderate or severe hepatic impairment (Child-Pugh class B or C),
  • Severe renal failure (estimated glomerular filtration rate <20 ml/min/1.73 m2),
  • Participation in a different research protocol (current or within 1 year),
  • Inability or unwillingness to adhere to standard treatment or to provide consent.

结局指标

主要结局

Change in left atrial ejection fraction

时间窗: 30 days

次要结局

  • Maximal post-procedural troponin T(48 h)

研究者

发起方
G.Gennimatas General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Spyridon Deftereos

Associate Professor of Cardiology

G.Gennimatas General Hospital

研究点 (3)

Loading locations...

相似试验